 | • レポートコード：GIR-2104Z13344 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮下注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮下注射の種類別市場規模（皮下注射器具、皮下注射薬、その他）、用途別市場規模（病院、診療所、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮下注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Becton Dickinson、Daiichi Sankyo、Sanofi、Roche、GSK、Eli Lilly、Asahi Kasei Pharma、Takeda Pharmaceutical、Antares Pharma, Inc.、Eisai Co.，Ltd、Chugai Pharmaceutical、Endo International、PenJet Corporation、Aspen Medical Group ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：皮下注射器具、皮下注射薬、その他 ・用途別分析2016年-2026年：病院、診療所、研究所、その他 ・皮下注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮下注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮下注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮下注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮下注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Subcutaneous Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Subcutaneous Injection size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Subcutaneous Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Subcutaneous Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Market segment by Application, can be divided into
Hospital
Clinic
Laboratory
Others
Market segment by players, this report covers
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Injection
1.2 Classification of Subcutaneous Injection by Type
1.2.1 Overview: Global Subcutaneous Injection Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Subcutaneous Injection Revenue Market Share by Type in 2020
1.2.3 Subcutaneous Injection Equipment
1.2.4 Subcutaneous Injection Drug
1.2.5 Others
1.3 Global Subcutaneous Injection Market by Application
1.3.1 Overview: Global Subcutaneous Injection Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Subcutaneous Injection Market Size & Forecast
1.5 Global Subcutaneous Injection Market Size and Forecast by Region
1.5.1 Global Subcutaneous Injection Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Subcutaneous Injection Market Size by Region, (2016-2021)
1.5.3 North America Subcutaneous Injection Market Size and Prospect (2016-2026)
1.5.4 Europe Subcutaneous Injection Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Subcutaneous Injection Market Size and Prospect (2016-2026)
1.5.6 South America Subcutaneous Injection Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Subcutaneous Injection Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Injection Market Drivers
1.6.2 Subcutaneous Injection Market Restraints
1.6.3 Subcutaneous Injection Trends Analysis
2 Company Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business
2.1.3 Becton Dickinson Subcutaneous Injection Product and Solutions
2.1.4 Becton Dickinson Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Becton Dickinson Recent Developments and Future Plans
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo Subcutaneous Injection Product and Solutions
2.2.4 Daiichi Sankyo Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Daiichi Sankyo Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Subcutaneous Injection Product and Solutions
2.3.4 Sanofi Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Subcutaneous Injection Product and Solutions
2.4.4 Roche Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK Subcutaneous Injection Product and Solutions
2.5.4 GSK Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GSK Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Subcutaneous Injection Product and Solutions
2.6.4 Eli Lilly Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Asahi Kasei Pharma
2.7.1 Asahi Kasei Pharma Details
2.7.2 Asahi Kasei Pharma Major Business
2.7.3 Asahi Kasei Pharma Subcutaneous Injection Product and Solutions
2.7.4 Asahi Kasei Pharma Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Asahi Kasei Pharma Recent Developments and Future Plans
2.8 Takeda Pharmaceutical
2.8.1 Takeda Pharmaceutical Details
2.8.2 Takeda Pharmaceutical Major Business
2.8.3 Takeda Pharmaceutical Subcutaneous Injection Product and Solutions
2.8.4 Takeda Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.9 Antares Pharma, Inc.
2.9.1 Antares Pharma, Inc. Details
2.9.2 Antares Pharma, Inc. Major Business
2.9.3 Antares Pharma, Inc. Subcutaneous Injection Product and Solutions
2.9.4 Antares Pharma, Inc. Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Antares Pharma, Inc. Recent Developments and Future Plans
2.10 Eisai Co.，Ltd
2.10.1 Eisai Co.，Ltd Details
2.10.2 Eisai Co.，Ltd Major Business
2.10.3 Eisai Co.，Ltd Subcutaneous Injection Product and Solutions
2.10.4 Eisai Co.，Ltd Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eisai Co.，Ltd Recent Developments and Future Plans
2.11 Chugai Pharmaceutical
2.11.1 Chugai Pharmaceutical Details
2.11.2 Chugai Pharmaceutical Major Business
2.11.3 Chugai Pharmaceutical Subcutaneous Injection Product and Solutions
2.11.4 Chugai Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Chugai Pharmaceutical Recent Developments and Future Plans
2.12 Endo International
2.12.1 Endo International Details
2.12.2 Endo International Major Business
2.12.3 Endo International Subcutaneous Injection Product and Solutions
2.12.4 Endo International Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Endo International Recent Developments and Future Plans
2.13 PenJet Corporation
2.13.1 PenJet Corporation Details
2.13.2 PenJet Corporation Major Business
2.13.3 PenJet Corporation Subcutaneous Injection Product and Solutions
2.13.4 PenJet Corporation Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 PenJet Corporation Recent Developments and Future Plans
2.14 Aspen Medical Group
2.14.1 Aspen Medical Group Details
2.14.2 Aspen Medical Group Major Business
2.14.3 Aspen Medical Group Subcutaneous Injection Product and Solutions
2.14.4 Aspen Medical Group Subcutaneous Injection Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Aspen Medical Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Subcutaneous Injection Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Subcutaneous Injection Players Market Share
3.2.2 Top 10 Subcutaneous Injection Players Market Share
3.2.3 Market Competition Trend
3.3 Subcutaneous Injection Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Subcutaneous Injection Revenue and Market Share by Type (2016-2021)
4.2 Global Subcutaneous Injection Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Subcutaneous Injection Revenue Market Share by Application (2016-2021)
5.2 Subcutaneous Injection Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Subcutaneous Injection Revenue by Type (2016-2026)
6.2 North America Subcutaneous Injection Revenue by Application (2016-2026)
6.3 North America Subcutaneous Injection Market Size by Country
6.3.1 North America Subcutaneous Injection Revenue by Country (2016-2026)
6.3.2 United States Subcutaneous Injection Market Size and Forecast (2016-2026)
6.3.3 Canada Subcutaneous Injection Market Size and Forecast (2016-2026)
6.3.4 Mexico Subcutaneous Injection Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Subcutaneous Injection Revenue by Type (2016-2026)
7.2 Europe Subcutaneous Injection Revenue by Application (2016-2026)
7.3 Europe Subcutaneous Injection Market Size by Country
7.3.1 Europe Subcutaneous Injection Revenue by Country (2016-2026)
7.3.2 Germany Subcutaneous Injection Market Size and Forecast (2016-2026)
7.3.3 France Subcutaneous Injection Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Subcutaneous Injection Market Size and Forecast (2016-2026)
7.3.5 Russia Subcutaneous Injection Market Size and Forecast (2016-2026)
7.3.6 Italy Subcutaneous Injection Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Subcutaneous Injection Revenue by Type (2016-2026)
8.2 Asia-Pacific Subcutaneous Injection Revenue by Application (2016-2026)
8.3 Asia-Pacific Subcutaneous Injection Market Size by Region
8.3.1 Asia-Pacific Subcutaneous Injection Revenue by Region (2016-2026)
8.3.2 China Subcutaneous Injection Market Size and Forecast (2016-2026)
8.3.3 Japan Subcutaneous Injection Market Size and Forecast (2016-2026)
8.3.4 South Korea Subcutaneous Injection Market Size and Forecast (2016-2026)
8.3.5 India Subcutaneous Injection Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Subcutaneous Injection Market Size and Forecast (2016-2026)
8.3.7 Australia Subcutaneous Injection Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Subcutaneous Injection Revenue by Type (2016-2026)
9.2 South America Subcutaneous Injection Revenue by Application (2016-2026)
9.3 South America Subcutaneous Injection Market Size by Country
9.3.1 South America Subcutaneous Injection Revenue by Country (2016-2026)
9.3.2 Brazil Subcutaneous Injection Market Size and Forecast (2016-2026)
9.3.3 Argentina Subcutaneous Injection Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Subcutaneous Injection Revenue by Type (2016-2026)
10.2 Middle East & Africa Subcutaneous Injection Revenue by Application (2016-2026)
10.3 Middle East & Africa Subcutaneous Injection Market Size by Country
10.3.1 Middle East & Africa Subcutaneous Injection Revenue by Country (2016-2026)
10.3.2 Turkey Subcutaneous Injection Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Subcutaneous Injection Market Size and Forecast (2016-2026)
10.3.4 UAE Subcutaneous Injection Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Subcutaneous Injection Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Subcutaneous Injection Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Subcutaneous Injection Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Subcutaneous Injection Revenue (USD Million) by Region (2016-2021)
Table 5. Global Subcutaneous Injection Revenue Market Share by Region (2021-2026)
Table 6. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 7. Becton Dickinson Major Business
Table 8. Becton Dickinson Subcutaneous Injection Product and Solutions
Table 9. Becton Dickinson Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 11. Daiichi Sankyo Major Business
Table 12. Daiichi Sankyo Subcutaneous Injection Product and Solutions
Table 13. Daiichi Sankyo Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Subcutaneous Injection Product and Solutions
Table 17. Sanofi Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Subcutaneous Injection Product and Solutions
Table 21. Roche Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GSK Corporate Information, Head Office, and Major Competitors
Table 23. GSK Major Business
Table 24. GSK Subcutaneous Injection Product and Solutions
Table 25. GSK Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Subcutaneous Injection Product and Solutions
Table 29. Eli Lilly Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Asahi Kasei Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Asahi Kasei Pharma Major Business
Table 32. Asahi Kasei Pharma Subcutaneous Injection Product and Solutions
Table 33. Asahi Kasei Pharma Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Takeda Pharmaceutical Major Business
Table 36. Takeda Pharmaceutical Subcutaneous Injection Product and Solutions
Table 37. Takeda Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Antares Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Antares Pharma, Inc. Major Business
Table 40. Antares Pharma, Inc. Subcutaneous Injection Product and Solutions
Table 41. Antares Pharma, Inc. Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eisai Co.，Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Eisai Co.，Ltd Major Business
Table 44. Eisai Co.，Ltd Subcutaneous Injection Product and Solutions
Table 45. Eisai Co.，Ltd Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Chugai Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Chugai Pharmaceutical Major Business
Table 48. Chugai Pharmaceutical Subcutaneous Injection Product and Solutions
Table 49. Chugai Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Endo International Corporate Information, Head Office, and Major Competitors
Table 51. Endo International Major Business
Table 52. Endo International Subcutaneous Injection Product and Solutions
Table 53. Endo International Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. PenJet Corporation Corporate Information, Head Office, and Major Competitors
Table 55. PenJet Corporation Major Business
Table 56. PenJet Corporation Subcutaneous Injection Product and Solutions
Table 57. PenJet Corporation Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Aspen Medical Group Corporate Information, Head Office, and Major Competitors
Table 59. Aspen Medical Group Major Business
Table 60. Aspen Medical Group Subcutaneous Injection Product and Solutions
Table 61. Aspen Medical Group Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Subcutaneous Injection Revenue (USD Million) by Players (2019-2021)
Table 63. Global Subcutaneous Injection Revenue Share by Players (2019-2021)
Table 64. Breakdown of Subcutaneous Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Subcutaneous Injection Players Head Office, Products and Services Provided
Table 66. Subcutaneous Injection Mergers & Acquisitions in the Past Five Years
Table 67. Subcutaneous Injection New Entrants and Expansion Plans
Table 68. Global Subcutaneous Injection Revenue (USD Million) by Type (2016-2021)
Table 69. Global Subcutaneous Injection Revenue Share by Type (2016-2021)
Table 70. Global Subcutaneous Injection Revenue Forecast by Type (2021-2026)
Table 71. Global Subcutaneous Injection Revenue by Application (2016-2021)
Table 72. Global Subcutaneous Injection Revenue Forecast by Application (2021-2026)
Table 73. North America Subcutaneous Injection Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Subcutaneous Injection Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Subcutaneous Injection Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Subcutaneous Injection Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Subcutaneous Injection Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Subcutaneous Injection Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Subcutaneous Injection Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Subcutaneous Injection Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Subcutaneous Injection Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Subcutaneous Injection Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Subcutaneous Injection Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Subcutaneous Injection Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Subcutaneous Injection Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Subcutaneous Injection Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Subcutaneous Injection Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Subcutaneous Injection Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Subcutaneous Injection Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Subcutaneous Injection Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Subcutaneous Injection Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Subcutaneous Injection Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Subcutaneous Injection Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Subcutaneous Injection Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Subcutaneous Injection Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Subcutaneous Injection Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Subcutaneous Injection Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Subcutaneous Injection Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Subcutaneous Injection Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Subcutaneous Injection Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Subcutaneous Injection Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Subcutaneous Injection Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Subcutaneous Injection Picture
Figure 2. Global Subcutaneous Injection Revenue Market Share by Type in 2020
Figure 3. Subcutaneous Injection Equipment
Figure 4. Subcutaneous Injection Drug
Figure 5. Others
Figure 6. Subcutaneous Injection Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Subcutaneous Injection Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Subcutaneous Injection Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Subcutaneous Injection Revenue Market Share by Region (2016-2026)
Figure 14. Global Subcutaneous Injection Revenue Market Share by Region in 2020
Figure 15. North America Subcutaneous Injection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Subcutaneous Injection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Subcutaneous Injection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Subcutaneous Injection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Subcutaneous Injection Market Drivers
Figure 20. Subcutaneous Injection Market Restraints
Figure 21. Subcutaneous Injection Market Trends
Figure 22. Becton Dickinson Recent Developments and Future Plans
Figure 23. Daiichi Sankyo Recent Developments and Future Plans
Figure 24. Sanofi Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Eli Lilly Recent Developments and Future Plans
Figure 28. Asahi Kasei Pharma Recent Developments and Future Plans
Figure 29. Takeda Pharmaceutical Recent Developments and Future Plans
Figure 30. Antares Pharma, Inc. Recent Developments and Future Plans
Figure 31. Eisai Co.，Ltd Recent Developments and Future Plans
Figure 32. Chugai Pharmaceutical Recent Developments and Future Plans
Figure 33. Endo International Recent Developments and Future Plans
Figure 34. PenJet Corporation Recent Developments and Future Plans
Figure 35. Aspen Medical Group Recent Developments and Future Plans
Figure 37. Global Subcutaneous Injection Revenue Share by Players in 2020
Figure 38. Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Subcutaneous Injection Revenue Market Share in 2020
Figure 40. Global Top 10 Players Subcutaneous Injection Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Subcutaneous Injection Revenue Share by Type in 2020
Figure 43. Global Subcutaneous Injection Market Share Forecast by Type (2021-2026)
Figure 44. Global Subcutaneous Injection Revenue Share by Application in 2020
Figure 45. Global Subcutaneous Injection Market Share Forecast by Application (2021-2026)
Figure 46. North America Subcutaneous Injection Sales Market Share by Type (2016-2026)
Figure 47. North America Subcutaneous Injection Sales Market Share by Application (2016-2026)
Figure 48. North America Subcutaneous Injection Revenue Market Share by Country (2016-2026)
Figure 49. United States Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Subcutaneous Injection Sales Market Share by Type (2016-2026)
Figure 53. Europe Subcutaneous Injection Sales Market Share by Application (2016-2026)
Figure 54. Europe Subcutaneous Injection Revenue Market Share by Country (2016-2026)
Figure 55. Germany Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Subcutaneous Injection Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Subcutaneous Injection Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Subcutaneous Injection Revenue Market Share by Region (2016-2026)
Figure 63. China Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Subcutaneous Injection Sales Market Share by Type (2016-2026)
Figure 70. South America Subcutaneous Injection Sales Market Share by Application (2016-2026)
Figure 71. South America Subcutaneous Injection Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Subcutaneous Injection Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Subcutaneous Injection Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Subcutaneous Injection Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Subcutaneous Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …
- 世界の皮下生物製剤市場規模・現状・予測（2021年-2027年） Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. M…
- 世界の皮下生物製剤市場規模・現状・予測（2021年-2027年） Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. M…
- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …